Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Is darolutamide effective for improving mental function?Does lipitor alter lipid metabolism in cells?Can lipitor improve muscle function in any way?What's the incidence rate of severe liver injury from tigecycline?Does lipitor's effectiveness decrease with high fiber intake?
See the DrugPatentWatch profile for vascepa
The provided information doesn’t include the number of trials that involve Vascepa treatment, so I can’t state a reliable count from your source.
“Trials involving Vascepa” can vary a lot depending on what you count, for example: - Only industry-sponsored trials vs. all sponsors - Interventional studies only vs. also observational studies - All phases (Phase 1–4) vs. a specific phase - Studies where Vascepa is the active comparator/arm vs. any mention in the record If you tell me which registry you’re using (ClinicalTrials.gov, EU CTR, etc.) and whether you want interventional-only and which phases, I can give you the exact number based on that scope.
If your intent is “trials that supported FDA approval/labeling,” that’s a narrower set than “all trials using Vascepa” and also depends on which indication (e.g., hypertriglyceridemia vs. cardiovascular risk). Share the indication and registry/scope, and I’ll pin down the right count.
Other Questions About Vascepa :